LENSAR, Inc. (LNSR)

NASDAQ: LNSR · Real-Time Price · USD
7.28
-0.19 (-2.54%)
Nov 20, 2024, 4:00 PM EST - Market closed
-2.54%
Market Cap 84.56M
Revenue (ttm) 48.87M
Net Income (ttm) -16.63M
Shares Out 11.61M
EPS (ttm) -1.46
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 43,341
Open 7.35
Previous Close 7.47
Day's Range 7.23 - 7.70
52-Week Range 2.10 - 7.96
Beta 0.59
Analysts n/a
Price Target n/a
Earnings Date Nov 7, 2024

About LNSR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2004
Employees 130
Stock Exchange NASDAQ
Ticker Symbol LNSR
Full Company Profile

Financial Performance

In 2023, LENSAR's revenue was $42.16 million, an increase of 19.25% compared to the previous year's $35.36 million. Losses were -$14.38 million, -27.77% less than in 2022.

Financial Statements

News

LENSAR, Inc. (LNSR) Q3 2024 Earnings Call Transcript

LENSAR, Inc. (NASDAQ:LNSR) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Cameron Radinovic - Investor Relations, Burns McClellan Nicholas Curtis - Chief Executive ...

12 days ago - Seeking Alpha

LENSAR Reports Third Quarter 2024 Results and Provides Business Update

24 ALLY Robotic Laser Cataract Systems™ placed in 3Q 2024 including 11 sales in EU and Southeast Asia; Robust backlog with 24 systems pending installation as of September 30, 2024

13 days ago - GlobeNewsWire

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of directors grant...

19 days ago - GlobeNewsWire

LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024

ORLANDO, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the treatm...

21 days ago - GlobeNewsWire

One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems

ORLANDO, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatm...

6 weeks ago - GlobeNewsWire

LENSAR to Participate in Two Upcoming Investor Conferences

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR®, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today ...

2 months ago - Business Wire

LENSAR, Inc. (LNSR) Q2 2024 Earnings Call Transcript

LENSAR, Inc. (NASDAQ:LNSR) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Cameron Radinovic - IR Nicholas Curtis - CEO & Director Thomas Staab - CFO Conference Call P...

3 months ago - Seeking Alpha

LENSAR Reports Second Quarter 2024 Results and Provides Business Update

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR®, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today ...

3 months ago - Business Wire

LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today a...

3 months ago - Business Wire

LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today a...

4 months ago - Business Wire

LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of catara...

6 months ago - Business Wire

LENSAR, Inc. (LNSR) Q1 2024 Earnings Call Transcript

LENSAR, Inc. (NASDAQ:LNSR) Q1 2024 Earnings Conference Call May 9, 2024 8:30 AM ET Company Participants Lee Roth - Burns McClellan Nicholas Curtis - CEO Thomas Staab - CFO Conference Call Participant...

6 months ago - Seeking Alpha

LENSAR Reports First Quarter 2024 Results and Provides Business Update

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of catara...

7 months ago - Business Wire

LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of catara...

7 months ago - Business Wire

LENSAR, Inc. (LNSR) Q4 2023 Earnings Call Transcript

LENSAR, Inc. (NASDAQ:LNSR) Q4 2023 Earnings Conference Call March 4, 2024 8:30 AM ET Company Participants Cameron Radinovic - Burns McClellan Nicholas Curtis - Chief Executive Officer Thomas Staab - ...

9 months ago - Seeking Alpha

LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of catara...

9 months ago - Business Wire

LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of catara...

9 months ago - Business Wire

LENSAR, Inc. (LNSR) Q3 2023 Earnings Call Transcript

LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Conference Call November 9, 2023 8:30 AM ET Company Participants Cameron Radinovic - Burns McClellan Nicholas Curtis - CEO Thomas Staab - CFO Conference Ca...

1 year ago - Seeking Alpha

LENSAR Reports Third Quarter 2023 Results and Provides Business Update

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of catara...

1 year ago - Business Wire

LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of catara...

1 year ago - Business Wire

LENSAR, Inc. (LNSR) Q2 2023 Earnings Call Transcript

LENSAR, Inc. (NASDAQ:LNSR) Q2 2023 Earnings Conference Call August 9, 2023 8:30 AM ET Company Participants Cameron Radinovic – Burns McClellan Nick Curtis – Chief Executive Officer Tom Staab – Chief ...

1 year ago - Seeking Alpha

LENSAR Reports Second Quarter 2023 Results and Provides Business Update

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of catara...

1 year ago - Business Wire

LENSAR to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment ...

1 year ago - Business Wire

LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment ...

1 year ago - Business Wire

LENSAR, Inc. (LNSR) Q1 2023 Earnings Call Transcript

LENSAR, Inc. (NASDAQ:LNSR) Q1 2023 Earnings Conference Call May 15, 2023 8:30 AM ET Company Participants Lee Roth - Burns McClellan Nicholas Curtis - Chief Executive Officer Thomas Staab - Chief Fina...

1 year ago - Seeking Alpha